LENZ Therapeutics, Inc.
LENZ
$29.54
$0.662.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.60% | 45.90% | 30.37% | -31.40% | -151.27% |
| Total Depreciation and Amortization | 525.00% | 150.00% | 350.00% | 66.67% | 33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.73% | 1,039.73% | 228.87% | 987.97% | -170.43% |
| Change in Net Operating Assets | 11.64% | -121.14% | -717.23% | -3,018.69% | 87.30% |
| Cash from Operations | 56.71% | 19.15% | -16.79% | -87.04% | -180.99% |
| Capital Expenditure | -- | -- | -454.17% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -177.20% | -246.34% | -265.93% | -- | -- |
| Cash from Investing | -178.18% | -247.38% | -266.10% | 300,100.00% | 505,866.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 26,410.84% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 97.71% | -- | -- | -- |
| Cash from Financing | 102.77% | 5,349.65% | -- | 105.90% | -109.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -170.99% | -36.17% | -187.93% | 134.93% | -160.27% |